Teachers Retirement System of the State of Kentucky’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Teachers Retirement System of the State of Kentucky’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,912	Closed	-$282K	–	1756
2019 Q3	$282K	Hold	2,912	–	–	﹤0.01%	1386
2019 Q2	$298K	Hold	2,912	–	–	﹤0.01%	1394
2019 Q1	$332K	Sell	2,912 -2,503	-46%	-$184K	﹤0.01%	1374
2018 Q4	$212K	Sell	5,415 -35,196	-87%	-$1.53M	﹤0.01%	1494
2018 Q3	$2.21M	Buy	40,611 +9,717	+31%	+$664K	0.03%	529
2018 Q2	$2.56M	Sell	30,894 -500	-2%	-$38.6K	0.03%	495
2018 Q1	$2.09M	Buy	31,394 +8,440	+37%	+$487K	0.03%	543
2017 Q4	$1.18M	Buy	+22,954	New	+$1.65M	0.01%	791

Teachers Retirement System of the State of Kentucky's ONCE Position: Q4 2019 in Review

Teachers Retirement System of the State of Kentucky sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 2,912 shares — an estimated $282K sold.

Teachers Retirement System of the State of Kentucky first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $2.56M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Teachers Retirement System of the State of Kentucky reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Teachers Retirement System of the State of Kentucky sold 2,912 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $282K.
Teachers Retirement System of the State of Kentucky first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Teachers Retirement System of the State of Kentucky's Spark Therapeutics, Inc. Common Stock position peaked at $2.56M in Q2 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Teachers Retirement System of the State of Kentucky's 13F filing for Q4 2019, filed 13 Feb 2020.